Latent Autoimmune Diabetes in Adults

Immunology
2
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Diamyd Medical
Diamyd MedicalSweden - Stockholm
1 program
1
recombinant human glutamic acid dehydrogenasePhase 21 trial
Active Trials
NCT04262479Completed14Est. May 2022
AS
AB ScienceFrance - Paris
1 program
1
recombinant human glutamic acid dehydrogenasePhase 2
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Infections and Latent Autoimmune Diabetes in AdultsN/A1 trial
Active Trials
NCT06167616Completed5,048Est. Oct 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Diamyd Medicalrecombinant human glutamic acid dehydrogenase
Novo NordiskInfections and Latent Autoimmune Diabetes in Adults

Clinical Trials (2)

Total enrollment: 5,062 patients across 2 trials

NCT04262479Diamyd Medicalrecombinant human glutamic acid dehydrogenase

Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes

Start: Mar 2020Est. completion: May 202214 patients
Phase 2Completed
NCT06167616Novo NordiskInfections and Latent Autoimmune Diabetes in Adults

Infections and Latent Autoimmune Diabetes in Adults

Start: Sep 2010Est. completion: Oct 20195,048 patients
N/ACompleted

Related Jobs in Immunology

Regulatory Affairs Manager(Immunology), Korea

AbbVie
Seoul, Seoul
15h ago

Regional Sales Trainer - Rheumatology (Mid Atlantic/Central)

AbbVie
Remote
15h ago

Field Reimbursement Manager - Rheumatology - Seattle, WA (North)

Johnson & Johnson
Seattle, Washington, United States of America
Yesterday
$100K - $175K/yr

Senior Medical Science Liaison, Dermatology - Indianapolis

Johnson & Johnson
Indianapolis, Indiana, United States
Yesterday
$137K - $236K/yr

Senior Area Business Specialist, Immunology - Detroit, MI - Johnson & Johnson Innovative Medicine

Johnson & Johnson
Detroit, Michigan, United States
Yesterday

Supply Chain and Procurement Controller

Ferring Pharmaceuticals
Hvidovre, Denmark
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

Related Indications

Rheumatoid Arthritis(477)Psoriasis(220)Ulcerative Colitis(153)Crohn's Disease(152)Atopic Dermatitis(151)Systemic Lupus Erythematosus(92)Arthritis, Rheumatoid(78)Plaque Psoriasis(59)Crohn Disease(50)Ankylosing Spondylitis(33)